# Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled Study

> **NCT05157204** · — · UNKNOWN · sponsor: **Ministry of Health, Saudi Arabia** · enrollment: 60 (estimated)

## Conditions studied

- Inflammatory Response
- Immunological Abnormality
- COVID-19

## Interventions

- **PROCEDURE:** measurment of interleukin-6 at exhaled condensate

## Key facts

- **NCT ID:** NCT05157204
- **Lead sponsor:** Ministry of Health, Saudi Arabia
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-26
- **Primary completion:** 2022-04-26
- **Final completion:** 2022-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157204, "Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05157204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*